A comprehensive review on the FDA's warning to 'Happiest Baby', producers of SNOO bassinet and sleep sacks. Understanding the recent commotion surrounding the producers of the SNOO bassinet, Happiest Baby, and the stern warning issued to them by the FDA is important. The Federal Drug Administration called out the company over their Extra-Small and Extra-Large SNOO sleep sacks, asserting that they are not approved. Moreover, reports concerning the certified 'pre-loved' SNOO program's potential issues were brought to light. This is not necessarily a direct order to discontinue use if you are a SNOO owner, yet adhering to standard sizes is suggested. The SNOO bassinet had earned high regard among parents, renowned for its soothing capability, utilizing motion, white noise, and a secure sleep sack. The latter feature promotes back sleeping in infants. However, an official warning was issued from the FDA to the company and its CEO, Dr. Harvey Karp, causing some concern. Explicitly on the warning list were issues related to sales of sleep sacks and Hospital SNOO bundles, which were initiated without undergoing FDA's evaluation and obtaining explicit permission from them. Though the FDA had authorized other SNOO products to help babies maintain back sleeping position, these specific products had missed the review process. The notice draws further attention to probable adverse consequences related to the refurbished SNOO program. Reports of unclean conditions, stains, and soiling have been disclosed. This may raise questions among current or potential SNOO users regarding the implications for their families. The issuance of warning letters from the FDA to companies typically suggests a suspected gross violation of federal mandates. In this context, Happiest Baby was notified to achieve necessary approvals before advertising its Extra-Small and Extra-Large SNOO sleep sacks and its 'hospital bundle.' The letter released by the FDA gave the company 15 days to formulate a response plan addressing these concerns. However, if the company disagrees, it can provide contrary evidence in response. Previously, the SNOO bassinet and its original sleep sack sizes-small, medium, and large attained FDA's authorization on successfully ensuring infants' back sleeping. Nevertheless, the two additional sizes and the 'hospital bundle' were not part of the initial authorization, and further research is required for them. The FDA emphasizes that these unapproved products cannot be claimed as FDA approved. Happiest Baby has responded to the warning proactively, stating its intent to cooperate and communicate effectively with the FDA. They reassured customers of their commitment to comply with the FDA's requirements for record-keeping, reporting, and quality management, and address issues raised in the letter. Notably though, an FDA warning does not equate to a recall and does not instruct consumers to cease the use of the product. However, cautioning that the extra-small variant could be too compressing on the infant's vital organs, whereas the extra large could potentially cover the infant's mouth or neck. Comparatively, most bassinets and sleep sacks do not have FDA's approval promoting back sleeping. However, they do not make similar claims as SNOO. Therefore, the refurbished program offered by SNOO is an attractive option for many parents due to the high price tag of a new SNOO, around $1700. The 'pre-loved' SNOO sells at a far more affordable rate, almost $900. Reports by FDA mention issues of unsanitary conditions, soiling, and stains, suggesting potential health risks to infants. It is recommended to return the 'pre-loved' SNOO, which has a one-year warranty upon observing any issues indicated by the FDA. One can also report these concerns to the FDA's MedWatch Voluntary Reporting Program. The 'hospital bundle' by SNOO is particularly for newborns in clinical settings like neonatal units. However, the FDA pointed out that the SNOO had only been approved for caregiver's home use and using it elsewhere could increase the risk of degrading the product due to a change in cleaning protocols. An issue was also raised concerning the SNOO's wheeled cart, which could potentially tip over. Finally, it is critical to note that an FDA warning doesn't correspond to a recall. It doesn't specifically instruct parents to stop using SNOO or warrant it as unsafe. The warning letter explicitly refers to size Extra-Small and Extra-Large sleep sacks, the 'hospital bundle,' and refurbished SNOOs. Thus, if you own a new SNOO and use a standard size sleep sack (small), it is unaffected by the FDA warning.